Future Perspective for ALK-Positive Anaplastic Large Cell Lymphoma with Initial Central Nervous System (CNS) Involvement: Could Next-Generation ALK Inhibitors Replace Brain Radiotherapy for the Prevention of Further CNS Relapse?
Central nervous system (CNS) involvement in anaplastic large cell lymphoma (ALCL) at diagnosis is rare and leads to poor prognosis with the use of the standard ALCL99 protocol alone. CNS-directed intensive chemotherapy, such as an increased dose of intravenous MTX, increased dose of dexamethasone, i...
Saved in:
Main Authors: | Makito Tanaka (Author), Hiroki Miura (Author), Soichiro Ishimaru (Author), Gen Furukawa (Author), Yoshiki Kawamura (Author), Kei Kozawa (Author), Seiji Yamada (Author), Fumitaka Ito (Author), Kazuko Kudo (Author), Tetsushi Yoshikawa (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathobiology of ALK-negative anaplastic large cell lymphoma
by: Stefano A. Pileri, et al.
Published: (2011) -
Educational Case: ALK-Negative Anaplastic Large Cell Lymphoma
by: Akira Satou MD, PhD, et al.
Published: (2020) -
Therapeutic Targeting of the Anaplastic Lymphoma Kinase (ALK) in Neuroblastoma-A Comprehensive Update
by: Annette K. Brenner, et al.
Published: (2021) -
Insight into systematic development of ALK (anaplastic lymphoma kinase) inhibitors towards NSCLC treatment
by: Vivek Yadav, et al.
Published: (2024) -
Analysis of Histologic Features Suspecting Anaplastic Lymphoma Kinase (ALK)-Expressing Pulmonary Adenocarcinoma
by: In Ho Choi, et al.
Published: (2015)